HighTower Advisors’s LianBio American Depositary Shares LIAN Stock Holding History
Bought
Maintained
Sold
Other funds holding LIAN
PA
TCM
VVA
2L
TCM
SG
AAA
HighTower Advisors's LIAN Position: Q3 2023 in Review
HighTower Advisors sold out of LianBio American Depositary Shares (LIAN) in Q3 2023, closing a stake of 32,500 shares — an estimated $74K sold.
HighTower Advisors first reported a position in LIAN in Q2 2022 and held it in 5 quarters. The position peaked at $80K in Q4 2022. 38 funds tracked by Wall St. Rank hold LIAN as of Q3 2023.
- HighTower Advisors reported no remaining LianBio American Depositary Shares position as of Q3 2023 after selling out during the quarter.
- HighTower Advisors sold 32,500 LianBio American Depositary Shares shares in Q3 2023, an estimated $74K.
- HighTower Advisors first reported a position in LianBio American Depositary Shares in Q2 2022 and held it in 5 quarters.
- HighTower Advisors's LianBio American Depositary Shares position peaked at $80K in Q4 2022.
- 38 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q3 2023.
Based on HighTower Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.